MetaCap

Who Owns CG Oncology Stock?

NASDAQ: CGONHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

79.47-2.43 (-2.97%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
111.67%
Institutional holders
342
  • Institutions 99.8%
  • Insiders 0.2%
  • Public and other 0.0%

Who owns CG Oncology stock?

Institutional investors own about 111.7% of CG Oncology's shares, spread across 342 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.23% of CGON.

The largest institutional holders are RTW Investments LP (9.53%), T. Rowe Price Investment Management, Inc. (7.53%) and Decheng Capital LLC (7.13%). Together, the top 10 institutions control 57.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their CGON positions and 2 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CGON

CG Oncology top institutional holders
InstitutionShares% HeldChange
RTW Investments LP8.51M9.53%0.0%
T. Rowe Price Investment Management, Inc.6.73M7.53%+1.7%
Decheng Capital LLC6.37M7.13%0.0%
Blackrock Inc.6.35M7.11%+1.5%
Wellington Management Group, LLP4.92M5.51%-7.7%
FMR, LLC4.59M5.14%+10.4%
TCG Crossover Management, LLC3.67M4.11%0.0%
Vanguard Capital Management LLC3.57M4.00%+7.8%
Vanguard Portfolio Management LLC3.52M3.94%+1.5%
State Street Corporation3.23M3.62%-5.9%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CGON

CG Oncology top fund holders
FundShares% Held
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund2.86M3.20%
T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App2.57M2.88%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.38M2.67%
iShares Trust-iShares Russell 2000 ETF1.91M2.14%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.72M1.93%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF1.54M1.73%
T. Rowe Price New Horizons Fund, Inc.1.11M1.25%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund860.03K0.96%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund808.01K0.90%
Fidelity Securities Fund-Fidelity Small Cap Growth Fund797.44K0.89%

Frequently asked questions

Who is the largest shareholder of CG Oncology?

RTW Investments LP is the largest institutional shareholder of CGON, owning 9.53% of shares outstanding (8.51M shares) as of its latest 13F filing.

What percentage of CG Oncology is owned by institutions?

Institutions own about 111.7% of CGON shares and 111.9% of the public float.

How much of CG Oncology do insiders own?

Insiders, such as officers and directors, own about 0.23% of CGON shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related